ArticleBMC psychiatry2026
Borderline personality disorder and substance use disorder: a clinical and psychopathological investigation.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBorderline Personality Disorder (BPD) is a severe psychiatric condition frequently associated with Substance Use Disorder (SUD), with high rates of comorbidity and poor clinical outcomes. Impulsivity and emotional dysregulation are core features shared by both disorders, suggesting common underlying mechanisms. However, less is known about the role of additional factors-such as alexithymia, coping strategies, and quality of life in contributing to dual diagnosis and SUD severity in individuals with BPD. This study aims to: (1) examine the clinical and demographic variables in a sample of patients with BPD comorbid with SUD, in comparison with a group of patients with BPD alone, and (2) identify clinical and psychopathological factors related to the presence of SUD and severity of SUD symptoms in the whole sample (BPD with and without SUD).
methodsSeventy-five outpatients diagnosed with BPD were recruited and divided into two groups: BPD with comorbid SUD (n = 43) and BPD without SUD (n = 32). Diagnoses were established using SCID-5-CV and SCID-5-PD. Participants were assessed using validated instruments measuring BPD severity (BPDSI-IV), impulsivity (BIS-11), alexithymia (TAS-20), coping strategies (CISS), addiction vulnerability and severity (ABQ), quality of life (SAT-P), and functioning (SOFAS). Group differences were analyzed using chi-square and ANCOVA. Hierarchical logistic and linear regressions were conducted to identify factors associated with the SUD presence and severity.
resultsPatients with BPD and SUD were more frequently male and showed earlier BPD onset, greater symptom severity, higher impulsivity, higher vulnerability to addiction, greater alexithymia, and more use of task-oriented coping strategies. Logistic regression showed that impulsivity and vulnerability to SUD were significantly associated with comorbid SUD, while alexithymia reduced the effect of gender. Motor impulsiveness independently contributed to the presence of dual diagnosis. Linear regression analyses indicated that alexithymia and impulsivity were variables most strictly associated with SUD severity, jointly explaining approximately 60% of the variance. Specifically, difficulty describing feelings and externally oriented thinking contributed to a greater SUD severity.
conclusionsImpulsivity and alexithymia appear to be key transdiagnostic factors underlying both the presence and severity of SUD in individuals with BPD. These findings highlight the importance of targeting deficits in emotional processing and impulse control in clinical interventions to improve outcomes in this clinical population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.